NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.500
+0.050 (3.45%)
At close: Feb 21, 2025, 4:00 PM
1.540
+0.040 (2.65%)
After-hours: Feb 21, 2025, 7:55 PM EST

NanoViricides Market Cap

NanoViricides has a market cap or net worth of $23.46 million as of February 21, 2025. Its market cap has increased by 76.41% in one year.

Market Cap
23.46M
Enterprise Value
19.50M
1-Year Change
76.41%
Ranking
Category
Stock Price
$1.50

Market Cap Chart

Since June 30, 2006, NanoViricides's market cap has decreased from $179.10M to $23.46M, a decrease of -86.90%. That is a compound annual growth rate of -10.32%.

History

DateMarket Cap% Change
Feb 21, 202523.50M14.63%
Dec 31, 202420.50M70.83%
Dec 29, 202312.00M-6.98%
Dec 30, 202212.90M-69.93%
Dec 31, 202142.90M40.20%
Dec 31, 202030.60M215.46%
Dec 31, 20199.70M-30.22%
Dec 31, 201813.90M-75.04%
Dec 29, 201755.70M-10.59%
Dec 30, 201662.30M-8.38%
Dec 31, 201568.00M-56.21%
Dec 31, 2014155.30M-35.32%
Dec 31, 2013240.10M222.72%
Dec 31, 201274.40M-18.33%
Dec 30, 201191.10M-54.65%
Dec 31, 2010200.90M79.38%
Dec 31, 2009112.00M12.68%
Dec 31, 200899.40M114.22%
Dec 31, 200746.40M-44.30%
Dec 29, 200683.30M-53.49%
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 784.21B
UnitedHealth Group 462.37B
Johnson & Johnson 384.45B
Novo Nordisk 370.84B
AbbVie 354.62B
Abbott Laboratories 230.98B
AstraZeneca 227.07B
Merck & Co. 221.80B
Market Cap Rankings